Abivax SA Sponsored ADR
ABVX Healthcare Biotechnology
- EPS
- −98.8%
- Free cash flow
- −48.3%
- Total debt
- −98.5%
Quarter to June 2026, against a year earlier
Follow ABVX
Alert me
Abivax SA Sponsored ADR (ABVX) EPS (diluted)
Abivax SA Sponsored ADR's EPS (diluted) for fiscal 2025 was −$5.46, compared with −$3.03 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$6.06. Over the past ten years it has ranged from −$5.46 (fiscal 2025) to −$1.83 (fiscal 2018) — the current reading is the lowest in ten years. Abivax SA Sponsored ADR ranks 463rd of 580 Biotechnology companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$5.46 | — |
| FY2024 | −$3.03 | — |
| FY2023 | −$3.71 | — |
| FY2022 | −$3.35 | — |
| FY2021 | −$2.92 | — |
| FY2020 | −$2.99 | — |
| FY2019 | −$2.81 | — |
| FY2018 | −$1.83 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | −$1.71 | — |
| Mar 2026 | −$0.71 | — |
| Dec 2025 | −$1.19 | — |
| Sep 2025 | −$2.45 | — |
| 6 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CORT Corcept Therapeutics Incorporated compare | $1.29 |
| ORKA Oruka Therapeutics, Inc. compare | −$2.12 |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −$2.25 |
| RYTM Rhythm Pharmaceuticals, Inc. compare | −$2.89 |
| AXSM Axsome Therapeutics, Inc. compare | −$3.06 |
| SYRE Spyre Therapeutics, Inc. compare | −$3.07 |
| CYTK Cytokinetics, Incorporated compare | −$6.04 |
| ABVX Abivax SA Sponsored ADR | −$6.06 |
| PRAX Praxis Precision Medicines, Inc. compare | −$12.93 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item